Medicare Enrolled

Dr. Judith Archibold, OD

Optometrist · Troy, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2222 6TH AVE, Troy, NY 12180
5182743123
In practice since 2011 (14 years)
NPI: 1871877472 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Archibold from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Archibold? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Archibold

Dr. Judith Archibold is an optometrist in Troy, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Archibold performed 2,701 Medicare services across 1,982 unique beneficiaries.

Between the years covered by Open Payments, Dr. Archibold received a total of $3,076 from 25 pharmaceutical and/or device companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Archibold is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 4% volume in NY $3,076 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,701
Medicare services
Top 4% in NY for optometrist
1,982
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~193 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
806 $81 $240
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
410 $22 $40
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
390 $22 $86
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
325 $11 $31
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
273 $41 $126
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
194 $61 $166
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
166 $26 $88
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
47 $26 $136
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
35 $7 $29
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $67 $204
Adenovirus detection test
A laboratory test that uses an immunoassay to detect the presence of adenovirus through direct visual observation.
21 $21 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,076
Total received (2018-2024)
Avg $439/year across 7 years
Top 13% in NY for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
80
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,076 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,289
2023
$451
2022
$350
2021
$68
2020
$153
2019
$82
2018
$683

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$290
Astellas Pharma US Inc
$202
ABBVIE INC.
$198
Amgen Inc.
$122
Apellis Pharmaceuticals, Inc.
$109
Mallinckrodt Hospital Products Inc.
$100
Alcon Vision LLC
$68
Genentech USA, Inc.
$53
Thea Pharma Inc.
$44
Oyster Point Pharma, Inc.
$43
Tarsus Pharmaceuticals, Inc.
$32
SUN PHARMACEUTICAL INDUSTRIES INC.
$29
Top 3 companies account for 53.5% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$465
Novartis Pharmaceuticals Corporation
$345
ABBVIE INC.
$220
Allergan Inc.
$210
Astellas Pharma US Inc
$202
Oyster Point Pharma, Inc.
$177
Alcon Vision LLC
$175
GENZYME CORPORATION
$125
Amgen Inc.
$122
Apellis Pharmaceuticals, Inc.
$109
TissueTech, Inc.
$103
Mallinckrodt Hospital Products Inc.
$100
AbbVie Inc.
$98
Aerie Pharmaceuticals, Inc.
$98
RxSight Inc
$88
Genentech USA, Inc.
$78
Regeneron Healthcare Solutions, Inc.
$69
SUN PHARMACEUTICAL INDUSTRIES INC.
$51
Shire North American Group Inc
$50
BIOTISSUE HOLDINGS, INC.
$45
Thea Pharma Inc.
$44
Tarsus Pharmaceuticals, Inc.
$32
Quidel Corporation
$29
Alimera Sciences, Inc.
$26
Allergan, Inc.
$17
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · CEREZYME · Cequa · Clareon · EYLEA · Eye Health · IC-8 Apthera IOL · ILUVIEN · IYUZEH · Izervay · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LUMIGAN · MIEBO · OZURDEX · PROKERA · Prokera · RESTASIS · Rhopressa · Rocklatan · Simbrinza · Syfovre · TEPEZZA · TYRVAYA · VUITY · VYZULTA · Vabysmo · XDEMVY · XIIDRA · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optometrist in Troy?
Compare optometrists in the Troy area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
130
Per 100K population
81.1
County median income
$86,663
Nearest hospital
SAMARITAN HOSPITAL OF TROY, NEW YORK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Archibold is a mixed practice specialist, with above-average Medicare volume (top 4% in NY), with low-engagement industry engagement in the top 13% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Archibold experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Archibold performed 806 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Archibold receive payments from pharmaceutical companies?
Yes. Dr. Archibold received a total of $3,076 from 25 companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Archibold's costs compare to other optometrists in Troy?
Dr. Archibold's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Archibold) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →